2025-08-29 - Analysis Report
Okay, here's the report analyzing TG Therapeutics Inc. (TGTX), incorporating the provided data.

## TG Therapeutics Inc. (TGTX) Stock Analysis

**Ticker:** TGTX
**Company Name:** TG Therapeutics Inc.
**Description:** TG Therapeutics Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

### 1. Performance vs. S&P 500 (VOO)

*   **TGTX Cumulative Return:** 50.55%
*   **VOO Cumulative Return:** 102.60%
*   **Absolute Divergence:** -138.8
*   **Divergence Range:** Max: 155.9, Min: -178.5
*   **Relative Divergence:** 11.9

**Analysis:** TGTX has significantly underperformed the S&P 500 (VOO) over the analyzed period. The relative divergence of 11.9 indicates that the current divergence is near the lower end of its historical range compared to VOO.

**Alpha/Beta Analysis:**

| Year       | CAGR     | MDD     | Alpha     | Beta    | Cap(B) |
|------------|----------|---------|-----------|---------|--------|
| 2015-2017  | -6.0%   | 56.5%   | -35.0%    | -0.1    | 1.3   |
| 2016-2018  | -8.0%   | 58.6%   | -26.0%    | 0.0     | 0.7   |
| 2017-2019  | 74.0%   | 58.6%   | 44.0%     | 0.0     | 1.8   |
| 2018-2020  | 402.0%  | 58.6%   | 382.0%    | -0.4    | 8.2   |
| 2019-2021  | 125.0%  | 63.5%   | 76.0%     | -0.5    | 3.0   |
| 2020-2022  | -76.0%  | 70.4%   | -78.0%    | -0.6    | 1.9   |
| 2021-2023  | -350.0% | 70.4%   | -368.0%   | -0.8    | 2.7   |
| 2022-2024  | 71.0%   | 73.1%   | 45.0%     | -0.9    | 4.8   |
| 2023-2025  | 57.0%   | 73.1%   | 3.0%     | 0.4    | 4.6   |

**Analysis:**

*   **CAGR & MDD:**  The table reveals periods of high growth (e.g., 2018-2020) interspersed with significant declines (e.g., 2021-2023). High Maximum Drawdown (MDD) values suggest high volatility.
*   **Alpha:**  Alpha values fluctuate, indicating periods of both outperformance and underperformance relative to the market.  The negative alpha values in recent years are concerning.
*   **Beta:** Beta values are generally low, fluctuating around zero, and negative in some periods. This suggests the stock's returns are not strongly correlated with the market.

### 2. Recent Price Action

*   **Current Price:** 28.96
*   **Previous Close:** 28.57
*   **Change:** 1.37%
*   **5-Day Moving Average:** 28.757
*   **20-Day Moving Average:** 28.4092
*   **60-Day Moving Average:** 34.2258

**Analysis:**  The stock is trading above both its 5-day and 20-day moving averages, suggesting short-term upward momentum. However, it is still below its 60-day moving average, indicating potential resistance. The 1.37% increase is a positive sign.

### 3. Market Risk Indicators & Signals

*   **Market Risk Indicator (MRI):** 0.3266 (Low Risk)
*   **RSI:** 68.38 (Approaching Overbought)
*   **PPO:** 1.1442
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.33)
*   **Recent (20-Day) Relative Divergence Change:** 1.6 (+) - Short-term increase
*   **Expected Return (%):** -879.1%

**Analysis:**

*   **MRI:** The low MRI suggests a relatively stable market environment.
*   **RSI:** The RSI is approaching overbought territory (above 70), which *could* signal a potential pullback soon.
*   **PPO:**  The Positive PPO suggests a upward trend in the short term.
*   **Hybrid Signal:** The hybrid signal recommends a high allocation to stocks which could suggest that the MRI is too low.
*   **Divergence Change:** The positive change in relative divergence over the past 20 days suggests a recent improvement in TGTX's performance relative to VOO, albeit from a low base.
*   **Expected Return:** The extremely negative expected return is a significant red flag.  This suggests that, based on the model, long-term investment in TGTX could significantly underperform the S&P 500.

### 4. Recent News & Significant Events

*   **2025-08-25:** Major business developments, regulatory changes, or market events.
*   **2025-08-27:** Analyst discussions on recent performance and outlook.
*   **2025-08-26:** Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-08-28:** Market experts highlighting risks and opportunities, advising monitoring of news and company announcements.

**Analysis:** The news snippets point to a volatile environment for TGTX, with significant events and analyst scrutiny. Investors should closely monitor news and company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-08-08 | 0.19 | 0.14 B$   |
| 2025-05-09 | 0.03 | 0.12 B$   |
| 2024-11-07 | 0.03 | 0.08 B$   |
| 2024-08-09 | 0.05 | 0.07 B$   |
| 2025-08-08 | 0.05 | 0.07 B$   |

**Analysis:**  The latest EPS of 0.19 is a positive sign, showing improvement from previous quarters. Revenue has also been increasing.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.14B  | 86.58%        |
| 2025-03-31 | $0.12B  | 87.14%        |
| 2024-12-31 | $0.11B  | 85.77%        |
| 2024-09-30 | $0.08B  | 88.86%        |
| 2024-06-30 | $0.07B  | 88.70%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-06-30 | $0.28B  | 10.20%  |
| 2025-03-31 | $0.24B  | 2.13%   |
| 2024-12-31 | $0.22B  | 10.49%  |
| 2024-09-30 | $0.19B  | 2.02%   |
| 2024-06-30 | $0.18B  | 3.87%   |

**Analysis:** Revenue is showing an upward trend. The profit margins are exceptionally high, which warrants further investigation to understand their sustainability. Equity is increasing, and ROE fluctuates but shows recent improvement.

### 7. 종합적인 분석 (Overall Analysis)

**Summary:**

*   **Underperformance:** TGTX has significantly underperformed the S&P 500, and the extremely negative expected return is a major concern.
*   **Volatility:** The stock exhibits high volatility, as evidenced by the MDD in the alpha/beta analysis.
*   **Recent Improvement:** There are recent positive signals, including increasing revenue, improved EPS, and a short-term upward trend in price. The low Market Risk Indicator (MRI) also suggests a stable market environment.
*   **High Profit Margins:** The unusually high profit margins need further scrutiny to ensure they are sustainable.
*   **News & Events:** The company is experiencing significant news and events that are driving volatility.
*   **Technical Indicators:** The RSI approaching overbought territory may signal a potential pullback.

**Conclusion:**

TGTX presents a mixed picture. The recent improvements in earnings and revenue are encouraging, as are the high profit margins. However, the historical underperformance relative to the S&P 500, the high volatility, and the very negative expected return are significant concerns.  Investors should proceed with caution, carefully monitor news and company announcements, and consider the potential risks before investing. A deeper dive into the reasons behind the high profit margins and the drivers of the negative expected return is highly recommended.
